| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 12/03/2009 | US20090298156 Thymidine Kinase Mutants and Fusion Proteins Having Thymidine Kinase and Guanylate Kinase Activities |
| 12/03/2009 | US20090298099 Gonococcal Proteins and Nucleic Acids |
| 12/03/2009 | US20090297647 Assays, method and compositions that exploit a mycobacterial iron acquistion pathway in cells |
| 12/03/2009 | US20090297644 Herbal compositions for the treatment of diseases of the oral cavity |
| 12/03/2009 | US20090297640 Nutritional composition for increasing creatine uptake in skeletal muscle |
| 12/03/2009 | US20090297639 Cosmetic treatement method for fighting against skin ageing effects |
| 12/03/2009 | US20090297621 Microparticles For The Treatment Of Disease |
| 12/03/2009 | US20090297619 Nanoparticulate anticonvulsant and immunosuppressive compositions |
| 12/03/2009 | US20090297617 Abuse-deterrent pharmaceutical compositions of opioids and other drugs |
| 12/03/2009 | US20090297612 Homogeneous, intrinsic radiopaque embolic particles |
| 12/03/2009 | US20090297611 Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with a tyrosine kinase inhibitor, delta opioid receptor antagonist, neurokinin receptor antagonist, or vcam inhibitor for treatment of asthma or chronic obstructive pulmonary disease |
| 12/03/2009 | US20090297609 Method of Biomolecule Immobilization On Polymers Using Click-Type Chemistry |
| 12/03/2009 | US20090297606 Gamma-lactam compounds for promoting bone growth |
| 12/03/2009 | US20090297602 Modified Release Loxoprofen Compositions |
| 12/03/2009 | US20090297601 Dosage form time-lagged of drugs for the therapy of insomnia |
| 12/03/2009 | US20090297600 Novel pharmaceutical formulation containing a biguanide and an angiotensin antagonist |
| 12/03/2009 | US20090297599 Pharmaceutical compositions containing rosuvastatin calcium |
| 12/03/2009 | US20090297598 Therapeutic combination |
| 12/03/2009 | US20090297597 Modified Release Ticlopidine Compositions |
| 12/03/2009 | US20090297596 Nanoparticulate and Controlled Release Compositions Comprising a Platelet Aggregation Inhibitor |
| 12/03/2009 | US20090297594 Oral Pharmaceutical Dosage Forms Comprising a Proton Pump Inhibitor and a NSAID |
| 12/03/2009 | US20090297591 Compositions And Methods For The Transdermal Delivery Of Pharmaceutical Compounds |
| 12/03/2009 | US20090297589 Method of treating burns using Avermectin compound |
| 12/03/2009 | US20090297583 for controlled release of bioactive agents such as drugs or biodrugs from e.g. a stent; polymeric matrix comprises an agent and a polyamideester having a design that was preselected to provide a predetermined release rate of the combination of agents from the medical article |
| 12/03/2009 | US20090297578 Biosoluble coating comprising anti-proliferative and anti-inflammatory agent combination for treatment of vascular disorders |
| 12/03/2009 | US20090297576 Local Delivery of PAR-1 Antagonists to Treat Vascular Complications |
| 12/03/2009 | US20090297574 Flexable spirally-rolled polymer tube for monitoring and treatment of brain injuries |
| 12/03/2009 | US20090297572 Drug-Containing Implants And Methods of Use Thereof |
| 12/03/2009 | US20090297567 Method For Ultrasound Triggered Drug Delivery Using Hollow Microbubbles With Controlled Fragility |
| 12/03/2009 | US20090297566 Oxygen-impervious packaging with optional oxygen scavenger, stabilized thyroid hormone compositions and methods for storing thyroid hormone pharmaceutical compositions |
| 12/03/2009 | US20090297563 Diagnosis And Treatment of Immune-Related Diseases |
| 12/03/2009 | US20090297542 Adp-ribosylating toxin from listeria monocytogenes |
| 12/03/2009 | US20090297540 Induction of Indoleamine 2,3-Dioxygenase in Dendritic Cells by TLR Ligands and Uses thereof |
| 12/03/2009 | US20090297536 Compositions, kits, and methods for identification, assessment, prevention and therapy of cancer |
| 12/03/2009 | US20090297533 Controlled release immunomodulator compositions and methods for the treatment of otic disorders |
| 12/03/2009 | US20090297528 Methods to identify compounds useful for the treatment of proliferative and differentiative disorders |
| 12/03/2009 | US20090297525 Compositions, kits and methods for identification, assessment, prevention and therapy of cancer |
| 12/03/2009 | US20090297518 Immunopotentiative composition |
| 12/03/2009 | US20090297517 Methods for treating il-18 mediated disorders |
| 12/03/2009 | US20090297512 Compositions and methods for modulating vascular development |
| 12/03/2009 | US20090297510 Inhibition of calpain reduces allergic inflammation |
| 12/03/2009 | US20090297508 Compositions and methods for treating hemostasis disorders associated with clec-2 signal transduction |
| 12/03/2009 | US20090297507 ADAM10 in Cancer Diagnosis, Detection and Treatment |
| 12/03/2009 | US20090297506 Classification of cancer |
| 12/03/2009 | US20090297502 Ccr2 antagonists for chronic organ transplantation rejection |
| 12/03/2009 | US20090297499 Use of charcoal for treating inflammatory conditions |
| 12/03/2009 | US20090297497 Methods and compositions for treating nephrogenic diabetes and insipidus |
| 12/03/2009 | US20090297494 Diagnostic and treatment of a mental disorder |
| 12/03/2009 | US20090297492 Method for Improving Cognitive Performance |
| 12/03/2009 | US20090297491 Compositions containing non-polar compounds |
| 12/03/2009 | US20090297487 Method for introducing sirna into cells by photochemical internalisation |
| 12/03/2009 | US20090297478 Methods and Compositions for the Treatment of Lupus Using Clofarabine |
| 12/03/2009 | US20090297477 Estriol Therapy for Autoimmune and Neurodegenerative Disease and Disorders |
| 12/03/2009 | US20090297476 Novel peptide inhibitors of hepatitis c virus replication |
| 12/03/2009 | US20090297473 Sulphonylpyrrole Hydrochloride Salts as Histone Deacetylases Inhibitors |
| 12/03/2009 | US20090297472 Hepatitis C Virus Inhibitors |
| 12/03/2009 | US20090297469 Cyanoacrylate Monomer Formulation Containing Diiodomethyl-p-tolylsulfone and 2,4,4'-Trichloro-2'-Hydroxydiphenyl Ether |
| 12/03/2009 | US20090297468 Mixtures Comprising Anthranilic Acid Amides and Cooling Agents as Cosmetic and Pharmaceutical Compositions for Alleviating Itching |
| 12/03/2009 | US20090297456 Swallowtail motifs for imparting water solubility to porphyrinic compounds |
| 12/03/2009 | US20090297454 Perfluoroalkyl-Containing Complexes, Process For Their Production As Well As Their Use |
| 12/03/2009 | DE202008015620U1 Phosphatbinder Phosphate binders |
| 12/03/2009 | DE20122900U1 Ubichinon Konzentrat Ubiquinone concentrate |
| 12/03/2009 | DE102008026793A1 C-Ring-substituierte Pregn-4-en-21,17-carbolactone, sowie diese enthaltende pharmazeutische Präparate C-ring-substituted pregn-4-ene-21,17-carbolactones, and pharmaceutical compositions containing them |
| 12/03/2009 | DE102008026284A1 Verfahren zur Herstellung von Ruthenium-Dienyl-Komplexen A process for preparing ruthenium complexes dienyl |
| 12/03/2009 | DE102008025893A1 Verfahren zur Herstellung von Fettsäureamiden mit gesättigten, ungesättigten oder Hydroxy-Fettsäuren Process for the preparation of fatty acid amides with saturated, unsaturated or hydroxy fatty acids |
| 12/03/2009 | CA2765190A1 Methods of treating mammals with eustachian tube dysfunctions |
| 12/03/2009 | CA2757437A1 Compositions and methods for immunotherapy |
| 12/03/2009 | CA2729812A1 Therapeutic agent for alzheimer's disease |
| 12/03/2009 | CA2729035A1 A new metformin glycinate salt for blood glucose control |
| 12/03/2009 | CA2726264A1 Hydroxy substituted thieno pyrimidinones as melanin concentrating hormone receptor-1 antagonists |
| 12/03/2009 | CA2726262A1 Imidazopyridine and related analogs as sirtuin modulators |
| 12/03/2009 | CA2726198A1 Inhibitor of analgesic tolerance |
| 12/03/2009 | CA2726148A1 Composition comprising 1, 3 /1, 6 beta glucan for reducing weight |
| 12/03/2009 | CA2726009A1 Dihydropyrazole derivatives as tyrosine kinase modulators for the treatment of tumours |
| 12/03/2009 | CA2725897A1 Novel substituted pyrazoles, 1,2,4-oxadiazoles, and 1,3,4-oxadiazoles |
| 12/03/2009 | CA2725788A1 Calcium/sodium salt of inositol tripyrophosphate as an allosteric effector of hemoglobin |
| 12/03/2009 | CA2725680A1 Heterocyclic compound |
| 12/03/2009 | CA2725618A1 Antiviral salts |
| 12/03/2009 | CA2725603A1 5-substituted isoindoline compounds |
| 12/03/2009 | CA2725563A1 Phenyl piperazine compounds, pharmaceutical composition including the same, and use thereof |
| 12/03/2009 | CA2725551A1 Methods of treating cancer of the central nervous system |
| 12/03/2009 | CA2725484A1 Percutaneously absorbable preparation |
| 12/03/2009 | CA2725342A1 Methods and compositions for sleep disorders and other disorders |
| 12/03/2009 | CA2725307A1 Novel benzothiophene oxide derivative and salt thereof |
| 12/03/2009 | CA2725220A1 Ant-ligands molecules and biological applications |
| 12/03/2009 | CA2725111A1 Substituted carbinol compound having a cyclic linker |
| 12/03/2009 | CA2725110A1 Benzene or thiophene derivative and use thereof as vap-1 inhibitor |
| 12/03/2009 | CA2725051A1 Probiotics to improve gut microbiota |
| 12/03/2009 | CA2724774A1 Pyrazolospiroketone acetyl-coa carboxylase inhibitors |
| 12/03/2009 | CA2724605A1 Prostaglandin prodrugs as hypotensive agents |
| 12/03/2009 | CA2724603A1 Pyrazolospiroketone acetyl-coa carboxylase inhibitors |
| 12/03/2009 | CA2724502A1 Adhesive preparation containing donepezil, and package of the same |
| 12/03/2009 | CA2724194A1 Method and composition for treating ocular hypertension and glaucoma |
| 12/03/2009 | CA2723587A1 Abrogating proinflammatory cytokine production during oncolytic reovirus therapy |
| 12/03/2009 | CA2723580A1 Modulating interstitial pressure and oncolytic viral delivery and distribution |
| 12/03/2009 | CA2723205A1 2, 6-diamino-pyrimidin- 5-yl-carboxamides as syk or jak kinases inhibitors |
| 12/03/2009 | CA2722093A1 Pharmaceutical compositions comprising brivaracetam |
| 12/03/2009 | CA2721851A1 Purine pi3k inhibitor compounds and methods of use |
| 12/03/2009 | CA2721665A1 Compounds including an anti-inflammatory pharmacore and methods of use |
| 12/03/2009 | CA2721491A1 Use of dronedarone or a pharmaceutically acceptable salt thereof, for the preparation of a medicament for regulating the potassium level in the blood |